“NAGLREITER® MDDO has shown continued financial growth through Q2 2022, met important milestones for numerous client projects, and has continued to invest in our equipment and facilities to benefit the MedTech community. We look forward to continuing on this path moving through the rest of the year and into 2023.”
Brett Naglreiter, President and CEO of NAGLREITER® MDDO, talks about the standing of the company through Q2. Watch the video below for more details.
Back to News